These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1409510)

  • 21. Alcoholic hepatic impairment complicating treatment with hepatotoxic antituberculosis drugs.
    Tiwari VK
    J Indian Med Assoc; 1996 Sep; 94(9):347-8. PubMed ID: 9019083
    [No Abstract]   [Full Text] [Related]  

  • 22. Antituberculosis drug-induced hepatotoxicity is uncommon in Tanzanian hospitalized pulmonary TB patients.
    Tostmann A; van den Boogaard J; Semvua H; Kisonga R; Kibiki GS; Aarnoutse RE; Boeree MJ
    Trop Med Int Health; 2010 Feb; 15(2):268-72. PubMed ID: 20409289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The impact of antituberculosis drugs upon liver function in patients with positive HBVM].
    Chen GQ
    Zhonghua Jie He He Hu Xi Za Zhi; 1989 Apr; 12(2):89-90, 126. PubMed ID: 2791129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of sodium nucleinate on the development of morphologic reactions during antibacterial therapy of experimental tuberculosis].
    Baranova TV
    Probl Tuberk; 1986; (12):46-50. PubMed ID: 3823082
    [No Abstract]   [Full Text] [Related]  

  • 25. [Anti-tuberculosis drug-induced hepatitis].
    Wada M
    Kekkaku; 2005 Sep; 80(9):607-11. PubMed ID: 16245792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the hepatotoxic effect of antituberculous drugs in tuberculosis patients abusing alcohol.
    Grymiński J; Lyczewska J; Styszewska H; Walczak J
    Pol Med J; 1970; 9(3):635-44. PubMed ID: 5452841
    [No Abstract]   [Full Text] [Related]  

  • 27. Risk factors for drug induced hepatitis with first-line antituberculosis drugs in hospitalized patients of pulmonary tuberculosis.
    Pore SM; Shinde K
    J Postgrad Med; 2014; 60(1):90-2. PubMed ID: 24625953
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatitis due to anti-tuberculous drugs.
    Aggarwal NP
    Indian J Chest Dis Allied Sci; 1992; 34(4):231-2. PubMed ID: 1302758
    [No Abstract]   [Full Text] [Related]  

  • 29. [Diagnosis of liver diseases in patients with pulmonary tuberculosis].
    El'kin AV; Ariél' BM; Nechaev VV
    Probl Tuberk; 1992; (7-8):15-8. PubMed ID: 1488430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effect of N-acetyl cystein on antituberculosis drug-induced hepatotoxicity.
    Filik L
    Eur J Gastroenterol Hepatol; 2011 Feb; 23(2):193; author reply 193. PubMed ID: 21228682
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of childhood tuberculosis: consensus statement of IAP Working Group.
    Amdekar YK
    Indian Pediatr; 1998 Dec; 35(12):1263-4. PubMed ID: 10216716
    [No Abstract]   [Full Text] [Related]  

  • 32. [Ultrasonic examination of the liver in patients with pulmonary tuberculosis].
    Ivanov AK; Dzodzuashvili KA
    Klin Med (Mosk); 1990 Jan; 68(1):100-3. PubMed ID: 2186199
    [No Abstract]   [Full Text] [Related]  

  • 33. [Unusual therapeutic approach in treatment of pulmonary tuberculosis in six year old girl].
    Saracević E; Dizdarević A; Mulaosmanović V
    Med Arh; 2004; 58(3):183-4. PubMed ID: 15484863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of a mathematic method of prognosis in adverse reactions to chemotherapy of tuberculosis].
    Kazakov KS; Kozarev MI
    Probl Tuberk; 1987; (2):43-5. PubMed ID: 3575279
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of complex treatment with tuberculin, splenin and antibacterial agents on the hemodynamic indices and immune state in patients with pulmonary tuberculosis].
    Bochkarev EG; Evstaf'ev IuA; Shcheglova VT
    Probl Tuberk; 1988; (2):38-42. PubMed ID: 3375216
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1985 Aug; 132(2):374-8. PubMed ID: 2862820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of splenin in the combined treatment of pulmonary tuberculosis patients].
    Spesivtsev OG; Gal'chanskaia LD; Sobolevskaia LI; Prosvetov IuV
    Probl Tuberk; 1985; (8):28-31. PubMed ID: 4059204
    [No Abstract]   [Full Text] [Related]  

  • 38. [Short course chemotherapy for pulmonary tuberculosis. 3. Initial intensive regimens including pyrazinamide].
    Suzuki T; Shimada M; Yamaguchi W; Kameda K; Okamura S; Aizawa H
    Kekkaku; 1983 Sep; 58(9):459-64. PubMed ID: 6663962
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effectiveness of the hepatoprotective activity of reamberine, remaxol, and ademethionine and risk assessment in their use in patients with respiratory tuberculosis and drug-induced liver injury].
    Sukhanov DS
    Ter Arkh; 2012; 84(11):26-9. PubMed ID: 23252243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intermittent chemotherapy of patients with fibrous-cavernous pulmonary tuberculosis in a hospital].
    Kovalenko NN; Ginzburg TS; Kunichkina SA
    Probl Tuberk; 1987; (11):35-7. PubMed ID: 3125538
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.